I don't mind diluting to buy ESS, the MS diagnostic, and Georgetown! Anyone complaining about those acquisitions is merely bashing to keep the price low. Gerald is leveraging MANF's future success in order to acquire fantastic opportunities now with very little cash. I have no complaints about that!! I wish the stock price were higher, but what Gerald has done in the last couple of months in expanding our pipeline is breathtaking.
We could pop at any time, or it might take several months. If it takes several months, that would not be good for me personally, but that's the breaks. The acquisitions were right.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links